Loading...
A GATA3-specific DNAzyme attenuates sputum eosinophilia in eosinophilic COPD patients: a feasibility randomized clinical trial
BACKGROUND: A subset of COPD-patients presents with eosinophilic airway inflammation. While treatment of asthmatic patients with the GATA3-specific DNAzyme SB010 attenuated sputum eosinophilia after allergen challenge, this specific treatment has not been evaluated in patients with COPD. Our objecti...
Na minha lista:
| Udgivet i: | Respir Res |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5883532/ https://ncbi.nlm.nih.gov/pubmed/29615049 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12931-018-0751-x |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|